Marktkapitalisierung Veränderung Datum
Alexandria Real Estate Equities USD 7.92B 538M 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
American Homes 4 Rent USD 10.16B 1.76B 2026-03
Amgen USD 189.89B 13.64B 2026-03
AvalonBay Communities USD 22.9B 2.69B 2026-03
Boston Properties USD 8.24B 2.46B 2026-03
Brandywine Realty USD 507M 217M 2025-12
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Camden Property USD 10.23B 1.48B 2026-03
COPT Defense Properties USD 3.47B 322M 2026-03
Cousins Properties USD 3.75B 580M 2026-03
Digital Realty USD 62.89B 9.74B 2026-03
Douglas Emmett USD 1.58B 262M 2026-03
EastGroup Properties USD 9.95B 446M 2026-03
Eli Lilly USD 869.02B 146.97B 2026-03
EPR Properties USD 3.82B 22M 2026-03
Equity Lifestyle Properties USD 12.1B 357M 2026-03
Gilead Sciences USD 172.99B 20.71B 2026-03
Healthpeak Properties Inc USD 11.42B 248M 2026-03
Highwoods Properties USD 2.36B 477M 2026-03
Hudson Pacific Properties USD 1.69B 1.1B 2026-06
Illumina USD 17.88B 2.74B 2026-03
Kilroy Realty USD 3.29B 1.13B 2026-03
LTC Properties USD 1.84B 170M 2026-03
Medical Properties USD 2.79B 217M 2026-03
Mid-America Apartment Communities USD 14.21B 2.03B 2026-03
National Health Investors USD 3.92B 280M 2026-03
ProLogis USD 123.22B 4.64B 2026-03
Quest Diagnostics USD 21.69B 2.39B 2026-03
Realty Income USD 57.05B 5.19B 2026-03
Rexford Industrial Realty USD 7.35B 1.66B 2026-03
SL Green Realty USD 2.62B 634M 2026-03
STAG Industrial USD 6.89B 29M 2026-03
Terreno Realty USD 6.53B 446M 2026-03
UDR USD 11.01B 1.11B 2026-03
Ventas USD 38.88B 2.54B 2026-03
Vornado Realty USD 4.9B 1.49B 2026-03